Background Current risk assessment models (RAMs) for prediction of venous
thromboembolism (VTE) risk in the outpatient cancer population have shown poor predictive …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous
thromboembolism is not recommended. Several risk prediction scores to identify cancer …

Current guidelines recommend that patients with cancer be assessed for venous
thromboembolism (VTE) risk at the time of chemotherapy initiation and periodically …

Background The stratification of outpatients on chemotherapy for breast, colorectal, lung,
and ovarian cancers at risk of venous thromboembolism (VTE) remains an unmet clinical …

Abstract Background The Khorana Score is a validated risk score for predicting 6‐month
incidence of cancer‐associated venous thromboembolism (CAT) among patients starting …

Importance The assessment of the risk of venous thromboembolism (VTE) among
outpatients with cancer represents an unsolved topic. Current international guidelines …

The Asian population is thought to have a low risk of venous thromboembolism (VTE), but
the epidemiology of VTE in cancer patients remains unclear. The National Health Insurance …

Venous thromboembolism (VTE) is common in cancer patients, and is associated with
significant morbidity and mortality. Several factors, including procoagulant agents secreted …

PURPOSE Venous thromboembolism (VTE), especially pulmonary embolism (PE) and
lower extremity deep vein thrombosis (LE-DVT), is a serious and potentially preventable …